Investments in biomedical research have paid large dividends in the form of groundbreaking treatments for a host of diseases. Efforts to accelerate such benefits often assume there is a linear progression that begins with an understanding of basic biological principles, and then advances to therapeutic development, evaluation, and ultimately clinical application. As a result, many initiatives focus on the stages that follow discovery. The Dartmouth Institute for Biomolecular Targeting (iTarget) infuses even early-stage mechanistic investigation with a sophisticated awareness of translational possibilities. This approach will ensure that knowledge of disease pathology provides focus and context to enhance the impact of even the most fundamental research. At the same time, it targets mechanistic investigations in directions that increase the probability of ultimate translational success. iTarget is structured (1) to accelerate the research productivity and scientific impact of four exceptional junior faculty members with interrelated interests in biomolecular target identification, validation, and inhibition; (2) to provide a supportive framework for mentoring by experienced and committed senior faculty; (3) to develop essential shared research resources not available at Dartmouth or our regional IDeA partners and to facilitate access to existing cores; and (4) to recruit new faculty to the Institute. With faculty engagement from 10 departments across the Faculty of Arts and Sciences, Geisel School of Medicine, and Thayer School of Engineering, our initiative is truly multidisciplinary. Dartmouth's collegial and highly interactive faculty have outstanding strength in curiosity-based discovery, healthcare delivery and population-based outcomes analysis, and the university has made key investments in translational research. iTarget will thus benefit from natural research synergies that complement, but do not overlap with our programmatic partners. In return, iTarget fills a critical role, bringing researchers together at the interface between basic and translational sciences. It will thus stimulate interdisciplinary and innovative research projects to address unmet therapeutic needs. It will also enhance the regional research infrastructure, providing cutting-edge strategies for generating proteins and other molecular targeting tools and for visualizing molecular interactions in purified systems and in cells. The He recovery system to be purchased with the funds requested in this supplement, will ensure the long-term sustainability of the NMR facility, one of the fundamental resources supported by iTarget, which enables cutting edge research by a number of NIGMS funded faculty.

Public Health Relevance

We propose to establish a new basic and preclinical targeting institute at Dartmouth that will support innovative bi-directional strategies to enhance understanding of biological mechanisms and translation of that knowledge into clinical practice. The Institute will catalyze the development of new therapeutic approaches to address cancer, chronic obstructive pulmonary disease, and respiratory syncytial virus infections, and establish a new paradigm for accelerating biomedical research. The proposed COBRE Institute of Biomolecular Targeting will provide unique resources to investigators at Dartmouth and our IDeA partners, enhancing research productivity and funding competitiveness across the region.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Exploratory Grants (P20)
Project #
3P20GM113132-05S1
Application #
10134610
Study Section
Program Officer
Davani, Behrous
Project Start
2016-05-15
Project End
2021-02-28
Budget Start
2020-06-15
Budget End
2021-02-28
Support Year
5
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Dartmouth College
Department
Biochemistry
Type
Schools of Medicine
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Nasa, Isha; Kettenbach, Arminja N (2018) Coordination of Protein Kinase and Phosphoprotein Phosphatase Activities in Mitosis. Front Cell Dev Biol 6:30
Popelka, Hana; Klionsky, Daniel J; Ragusa, Michael J (2018) An atypical BAR domain protein in autophagy. Autophagy 14:1155-1156
Cabrera, Jorge Ruben; Charron, Audra J; Leib, David A (2018) Neuronal subtype determines HSV-1 Latency-Associated-Transcript (LAT) promoter activity during latency. J Virol :
Olmedillas, Eduardo; Cano, Olga; Martínez, Isidoro et al. (2018) Chimeric Pneumoviridae fusion proteins as immunogens to induce cross-neutralizing antibody responses. EMBO Mol Med 10:175-187
Hvorecny, Kelli L; Dolben, Emily; Moreau-Marquis, Sophie et al. (2018) An epoxide hydrolase secreted by Pseudomonas aeruginosa decreases mucociliary transport and hinders bacterial clearance from the lung. Am J Physiol Lung Cell Mol Physiol 314:L150-L156
Holland, Jack; Pan, Qinxin; Grigoryan, Gevorg (2018) Contact prediction is hardest for the most informative contacts, but improves with the incorporation of contact potentials. PLoS One 13:e0199585
Young, Lorna E; Higgs, Henry N (2018) Focal Adhesions Undergo Longitudinal Splitting into Fixed-Width Units. Curr Biol 28:2033-2045.e5
Kettenbach, Arminja N; Schlosser, Kate A; Lyons, Scott P et al. (2018) Global assessment of its network dynamics reveals that the kinase Plk1 inhibits the phosphatase PP6 to promote Aurora A activity. Sci Signal 11:
Lyons, Scott P; Jenkins, Nicole P; Nasa, Isha et al. (2018) A Quantitative Chemical Proteomic Strategy for Profiling Phosphoprotein Phosphatases from Yeast to Humans. Mol Cell Proteomics 17:2447-2461
Bricio-Moreno, Laura; Sheridan, Victoria H; Goodhead, Ian et al. (2018) Evolutionary trade-offs associated with loss of PmrB function in host-adapted Pseudomonas aeruginosa. Nat Commun 9:2635

Showing the most recent 10 out of 56 publications